Kewaunee Scientific Corp (KEQU) earnings date, market-implied expected move, and options open interest by expiry

earnings room

34.70+1.73%

Next report

fiscal Q2 2027

Dec 16

after close · estimated date

days out

Intraday

−0.86% since 10 AM

High 35.00 at 10:45 am ET, low 34.70 at 11:00 am ET.

Revenue flow

Q4 FY2026 derived from the annual figures · change vs Q3 FY2026

KEQU kept 5.17% of Q4 FY2026 revenue as profit. Revenue +2.88% on Q3 FY2026, −7.45% on Q4 FY2025.

Revenue$71M

Gross profit$21M29.75%

Operating income$5M7.31%

Pre-tax income$5M

Net income$4M5.17%

Cost of revenue

$50M · 70.25%

Operating expenses

$16M · 22.45%

Tax

$1M · 1.49%

Other expense leaves

$460,000 · 0.64%

KEQU files a 10-K for this quarter rather than a 10-Q, so these lines are the full year less the three quarters before it, not figures filed for the quarter ended Apr 30 '26. Ribbon thickness is the dollar amount.

Expected move

No options chain priced for this ticker yet.

Linked exposure

placeholder

No linked names measured for this ticker yet.

Positioning

placeholder

No options positioning captured for this ticker yet.

Earnings history

implied in pale · realized in full ink

Q1 FY27—

−1.41%—

3-quarter memory

Event sensitivity

release-day history · not a forecast

CPROFcorporate profits2.3×up 7 of 11±5.3% vs ±2.3% · 11
GDPgross domestic product1.8×up 10 of 18±4.1% vs ±2.3% · 18
FOMCrate decision0.8×up 12 of 23±2.0% vs ±2.3% · 23
PCEpersonal income & outlays0.8×up 10 of 18±1.8% vs ±2.3% · 18
PPIproducer prices0.7×up 6 of 9±1.6% vs ±2.3% · 9
NFPjobs report0.6×up 6 of 9±1.4% vs ±2.3% · 9
CPIconsumer prices0.5×up 3 of 9±1.2% vs ±2.3% · 9

Past release days against KEQU’s ordinary ±2.3% day, from our own stored closes. History, not a forecast; kinds with fewer than six releases are omitted.

Track KEQU

Watchlist prices, news filtered to it, and its next report on your desk.

Market-implied ranges describe what current option prices imply, never a forecast. Prices via Intrinio.